A Risk-Benefit Assessment of Risperidone for the Treatment of Behavioural and Psychological Symptoms in Dementia

Author: Zaudig M.  

Publisher: Adis International

ISSN: 0114-5916

Source: Drug Safety, Vol.23, Iss.3, 2000-09, pp. : 183-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract